Next Article in Journal
Actinotignum schaalii Abscess in a Patient with Common Variable Immunodeficiency
Next Article in Special Issue
Emerging Prevention and Treatment Strategies to Control COVID-19
Previous Article in Journal
Histopathological and Molecular Study of Pacific Oyster Tissues Provides Insights into V. aestuarianus Infection Related to Oyster Mortality
Previous Article in Special Issue
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
Open AccessReview

Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations

1
Department of Pathophysiology, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum, 85–094 Bydgoszcz, Poland
2
Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, 02–607 Warsaw, Poland
3
Department of Cardio–Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, 6229 Maastricht, The Netherlands
4
Thoracic Research Centre, Innovative Medical Forum, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum, 85–796 Bydgoszcz, Poland
*
Author to whom correspondence should be addressed.
Pathogens 2020, 9(6), 493; https://doi.org/10.3390/pathogens9060493
Received: 14 May 2020 / Revised: 12 June 2020 / Accepted: 18 June 2020 / Published: 20 June 2020
(This article belongs to the Special Issue SARS-CoV Infections)
Infection with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID–19). Elucidating the changes in hematological parameters in SARS–CoV–2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression. View Full-Text
Keywords: coronavirus disease 2019 COVID–19; severe acute respiratory syndrome coronavirus 2 SARS–CoV–2; hematology; hemostasis; cytokine storm coronavirus disease 2019 COVID–19; severe acute respiratory syndrome coronavirus 2 SARS–CoV–2; hematology; hemostasis; cytokine storm
Show Figures

Figure 1

MDPI and ACS Style

Słomka, A.; Kowalewski, M.; Żekanowska, E. Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations. Pathogens 2020, 9, 493.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop